Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 3 | nsp16:Q3S; | CL-1a_3f; |
| 52 | nsp16:Q52-; | CL-3b; |
| 6 | nsp16:Q6L; | CL-1a_3d;CL-3b;CL-3d; |
| 6 | nsp16:Q6R; | CL-2;CL-3d; |
| 87 | nsp16:Q87H; | CL-3e; |
| 19 | nsp16:R19G; | CL-1a_3b; |
| 216 | nsp16:R216L; | CL-3b; |
| 232 | nsp16:R232G; | CL-2;CL-3a; |
| 255 | nsp16:R255K; | CL-3b;CL-3d;CL-3e; |
| 255 | nsp16:R255S; | CL-3b;CL-3d;CL-3e; |
| 279 | nsp16:R279G; | CL-3c; |
| 279 | nsp16:R279K; | CL-3e; |
| 287 | nsp16:R287-; | CL-3f; |
| 287 | nsp16:R287I; | CL-1a_3e;CL-3b;CL-3e;CL-3f; |
| 287 | nsp16:R287K; | CL-3b; |
| 66 | nsp16:R66-; | CL-3b; |
| 66 | nsp16:R66K; | CL-1a_3d; |
| 86 | nsp16:R86K; | CL-1a;CL-2; |
| 109 | nsp16:S109L; | CL-3e; |
| 129 | nsp16:S129-; | CL-3e; |
| 129 | nsp16:S129G; | CL-3b;CL-3e; |
| 200 | nsp16:S200-; | CL-3e; |
| 202 | nsp16:S202F; | CL-1a;CL-3b; |
| 240 | nsp16:S240-; | CL-3f;CL-5; |
| 240 | nsp16:S240F; | CL-1a_3d; |
| 241 | nsp16:S241F; | CL-2;CL-3c; |
| 241 | nsp16:S241P; | CL-1a_3d;CL-3b; |
| 243 | nsp16:S243F; | CL-2; |
| 248 | nsp16:S248G; | CL-3e; |
| 248 | nsp16:S248N; | CL-3d; |
| 261 | nsp16:S261-; | CL-3d;CL-3e; |
| 276 | nsp16:S276-; | CL-3d;CL-3e;CL-3f; |
| 276 | nsp16:S276I; | CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
| 292 | nsp16:S292N; | CL-3c;CL-3d; |
| 2 | nsp16:S2G; | CL-3e; |
| 33 | nsp16:S33-; | CL-3d;CL-3f; |
| 33 | nsp16:S33G; | CL-3d; |
| 33 | nsp16:S33N; | CL-3e; |
| 33 | nsp16:S33R; | CL-1a_3d;CL-3d;CL-3e; |
| 120 | nsp16:T120-; | CL-3e; |
| 136 | nsp16:T136-; | CL-3e;CL-3f; |
| 136 | nsp16:T136I; | CL-1a_3f; |
| 140 | nsp16:T140-; | CL-1a_3f;CL-3b;CL-3d;CL-3e;CL-3f; |
| 140 | nsp16:T140A; | CL-3e; |
| 140 | nsp16:T140K; | CL-1a_3c; |
| 191 | nsp16:T191-; | CL-3f; |
| 195 | nsp16:T195-; | CL-3e; |
| 257 | nsp16:T257-; | CL-3e; |
| 257 | nsp16:T257I; | CL-3b;CL-3e;CL-5; |
| 35 | nsp16:T35-; | CL-3a;CL-3b;CL-3c;CL-3e;CL-3f; |
Page 219 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com